Valuation (48%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -2.31 | 91.63 |
| PEG Ratio (TTM) | -0.18 | -1.65 |
| P/S Ratio (TTM) | 0.22 | 1.29 |
| P/B Ratio (TTM) | 0.89 | 1.89 |
| P/FCF Ratio (TTM) | -4.33 | -1.38 |
| Price to 5YR AVG Earnings Ratio | 14.34 | 22.56 |
| Price to 5YR AVG FCF Ratio | 30.53 | 8.44 |
Profitability (5%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -7.61% | 2.45% |
| ROE (TTM) | -32.02% | 3.70% |
| Net Profit Margin (TTM) | -9.34% | 1.18% |
| ROIC 5YR AVG | 8.56% | 19.25% |
Growth (65%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -96.18% | 305.07% | 152.40% |
| Revenue | 2.08% | 8.59% | 7.93% |
| Net Income | -96.46% | 301.93% | 150.46% |
| Cash Flow | -32.15% | 86.21% | 47.48% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.46 | 2.66 |
| Quick Ratio (TTM) | 2.17 | 1.79 |
| D/E Ratio (TTM) | 3.24 | 1.10 |
| Interest Coverage (TTM) | 3.87 | 10.81 |
| Piotroski F-Score | 2 | 6 |
| Altman Z-Score | 1.34 | 3.19 |
| LTL to 5YR AVG FCF | 113.08 | 8.38 |
| Shares Outstanding Growth 5YR AVG | 0.39% | 2.08% |